Related Experiment Video
Updated: Jul 7, 2026

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
Published on: December 19, 2014
Macrophage activation syndrome triggered by Candida parapsilosis-related cochlear implant infection
Begum Bahar Yilmaz1, Muhammed Talha Karadogan2, Alper Tabaru3
1Otorhinolaryngology and Head and Neck Surgery, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey. begumbahar.bbb@gmail.com.
Background:
Cochlear implant-related infections may rarely lead to life-threatening systemic complications. Macrophage Activation Syndrome (MAS) is a severe and potentially fatal hyperinflammatory condition. MAS associated with CI infection has not been previously reported in pediatric patients.
Case Presentation:
We present a 13-year-old female patient who developed MAS secondary to Candida parapsilosis-related sepsis associated with cochlear implant (CI). Despite broad-spectrum antibacterial and antifungal therapy, the patient's clinical course deteriorated with pancytopenia, hyperferritinemia, and acute liver failure. She fulfilled HLH-2004 criteria and was diagnosed with MAS. Multidisciplinary treatment approach included plasmapheresis, high-dose pulse corticosteroids and CI explantation, resulted in clinical recovery. Implant site cultures revealed that Candida parapsilosis, a fungal pathogen known for biofilm formation and implant-related infections. Following explantation, the patient showed gradual improvement with immunosuppressive therapy and supportive care. Successful cochlear implant reimplantation was performed two months later.
Conclusion:
CI-related infections and related systemic complications are rare but severe. This is the first reported pediatric case of MAS triggered by cochlear implant-related sepsis. Early recognition of MAS and multidisciplinary management are essential to improve outcome and survival.
Insights
Cochlear implant infections can cause severe Macrophage Activation Syndrome (MAS) in children. This case highlights the importance of early recognition and multidisciplinary treatment for improved outcomes.
Area of Science:
- Pediatric Infectious Diseases
- Critical Care Medicine
- Otolaryngology
Background:
- Cochlear implant (CI) infections are rare but can lead to severe systemic complications.
- Macrophage Activation Syndrome (MAS) is a life-threatening hyperinflammatory condition.
- Pediatric cases of MAS secondary to CI infection have not been previously documented.
Purpose of the Study:
- To report the first pediatric case of MAS triggered by a cochlear implant infection.
- To emphasize the diagnostic challenges and treatment strategies for CI-related MAS.
- To highlight the critical role of a multidisciplinary approach in managing such rare complications.
Main Methods:
- Case presentation of a 13-year-old female with MAS secondary to Candida parapsilosis sepsis from a CI.
- Diagnostic workup included HLH-2004 criteria fulfillment, revealing pancytopenia, hyperferritinemia, and liver failure.
- Treatment involved plasmapheresis, high-dose corticosteroids, CI explantation, and subsequent reimplantation.
Main Results:
- The patient developed MAS despite broad-spectrum antimicrobial and antifungal therapy.
- Clinical recovery was achieved following a multidisciplinary treatment approach including CI explantation.
- Candida parapsilosis was identified as the causative pathogen, known for biofilm formation.
- Successful cochlear implant reimplantation was performed two months post-explantation.
Conclusions:
- Cochlear implant-related infections can lead to severe systemic complications like MAS.
- This is the first reported pediatric case of MAS associated with cochlear implant sepsis.
- Early diagnosis and prompt multidisciplinary management are crucial for improving survival and outcomes in pediatric CI-related MAS.
Related Concept Videos
Cryptococcal Meningitis
Candidiasis